$ARRT
Artisan Consumer Goods, Inc.

2023 Q4 Form 10-K Financial Statement

#000147793223007594 Filed on October 12, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q2 2023
Revenue $0.00 $7.648K
YoY Change -100.0%
Cost Of Revenue $0.00 $9.400K
YoY Change -100.0%
Gross Profit $0.00 -$1.752K
YoY Change -100.0%
Gross Profit Margin -22.91%
Selling, General & Admin $13.71K $38.10K
YoY Change 131.59% 27.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $750.00 $3.000K
YoY Change 0.0%
% of Gross Profit
Operating Expenses $14.46K $41.10K
YoY Change 116.84% 35.66%
Operating Profit -$14.46K -$42.85K
YoY Change 166.35% 41.45%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $29.00
YoY Change -100.35%
Pretax Income -$14.46K -$42.83K
YoY Change 166.3% 7.08%
Income Tax
% Of Pretax Income
Net Earnings -$14.46K -$42.83K
YoY Change 166.35% 11.13%
Net Earnings / Revenue -559.95%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 4.400M shares 4.400M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q2 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $2.070K
YoY Change -100.0% -79.3%
Cash & Equivalents $0.00 $2.067K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $0.00 $0.00 $0.00
Prepaid Expenses
Receivables $0.00
Other Receivables
Total Short-Term Assets $0.00 $2.067K $2.070K
YoY Change -100.0% -90.51% -89.65%
LONG-TERM ASSETS
Property, Plant & Equipment $3.125K
YoY Change -48.98%
Goodwill
YoY Change
Intangibles $1.000K $1.000K
YoY Change 0.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.625K $4.125K $4.120K
YoY Change -53.37% -42.11% -58.8%
TOTAL ASSETS
Total Short-Term Assets $0.00 $2.067K $2.070K
Total Long-Term Assets $2.625K $4.125K $4.120K
Total Assets $2.625K $6.192K $6.190K
YoY Change -85.31% -78.58% -79.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $49.55K $49.52K $49.52K
YoY Change 2.73% 8.4% -0.96%
Accrued Expenses $48.26K $48.26K $48.26K
YoY Change -0.03% -0.06% -3.48%
Deferred Revenue
YoY Change
Short-Term Debt $184.7K $168.7K
YoY Change 11.47% 12.45%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $282.5K $266.4K $266.5K
YoY Change 7.75% 7.36% 6.58%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $282.5K $266.4K $266.5K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $282.5K $266.5K
YoY Change 7.75% 6.58%
SHAREHOLDERS EQUITY
Retained Earnings -$19.28M -$19.26M
YoY Change 0.22%
Common Stock $4.400K $4.400K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$279.8K -$260.3K -$260.2K
YoY Change
Total Liabilities & Shareholders Equity $2.625K $6.192K $6.190K
YoY Change -85.31% -78.58% -79.37%

Cashflow Statement

Concept 2023 Q4 2023 Q2 2023
OPERATING ACTIVITIES
Net Income -$14.46K -$42.83K
YoY Change 166.35% 11.13%
Depreciation, Depletion And Amortization $750.00 $3.000K
YoY Change 0.0%
Cash From Operating Activities -$16.32K -$35.94K
YoY Change 1.49% 23.65%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.000K $24.45K
YoY Change -95.34% -52.73%
NET CHANGE
Cash From Operating Activities -16.32K -$35.94K
Cash From Investing Activities $0.00
Cash From Financing Activities 1.000K $24.45K
Net Change In Cash -15.32K -$11.49K
YoY Change -385.29% -190.79%
FREE CASH FLOW
Cash From Operating Activities -$16.32K -$35.94K
Capital Expenditures $0.00
Free Cash Flow -$35.94K
YoY Change 88.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4400048 shares
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The Company provides estimates for its common stock valuations and valuation allowances for deferred taxes.</p>
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001530425
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4400048 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4400048 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4400048 shares
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023 dei Entity File Number
EntityFileNumber
000-54838
CY2023 dei Entity Registrant Name
EntityRegistrantName
ARTISAN CONSUMER GOODS, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1240056
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
999 N Northlake Way Ste 203
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98103-3442
CY2023 dei City Area Code
CityAreaCode
206
CY2023 dei Local Phone Number
LocalPhoneNumber
517-7141
CY2023 dei Security12b Title
Security12bTitle
Common
CY2023 dei Trading Symbol
TradingSymbol
ARRT
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Public Float
EntityPublicFloat
175000 usd
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4400048 shares
CY2023 dei Auditor Firm
AuditorFirmId
5041
CY2023 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2023 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2067 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13555 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
0 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
8224 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
2067 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
21779 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5875 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2875 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3125 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6125 usd
CY2023Q2 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
1000 usd
CY2022Q2 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
1000 usd
CY2023Q2 us-gaap Other Assets
OtherAssets
4125 usd
CY2022Q2 us-gaap Other Assets
OtherAssets
7125 usd
CY2023Q2 us-gaap Assets
Assets
6192 usd
CY2022Q2 us-gaap Assets
Assets
28904 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
49522 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
45685 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
48257 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
48286 usd
CY2023Q2 arrt Due To Related Parties Currents
DueToRelatedPartiesCurrents
168666 usd
CY2022Q2 arrt Due To Related Parties Currents
DueToRelatedPartiesCurrents
154216 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
266445 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
248187 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
4400 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
4400 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18984200 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18984200 usd
CY2023Q2 arrt Stock Shares Subscribed But Unissued Value
StockSharesSubscribedButUnissuedValue
9398 usd
CY2022Q2 arrt Stock Shares Subscribed But Unissued Value
StockSharesSubscribedButUnissuedValue
7543 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19258251 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19215426 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-260253 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-219283 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6192 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28904 usd
CY2023 us-gaap Revenues
Revenues
7648 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
9400 usd
CY2023 us-gaap Gross Profit
GrossProfit
-1752 usd
CY2022 us-gaap Gross Profit
GrossProfit
0 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1855 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1470 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
26749 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
24071 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9498 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1881 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2875 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
41102 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
30297 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-42854 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-30297 usd
CY2023 us-gaap Other Income
OtherIncome
-29 usd
CY2022 us-gaap Other Income
OtherIncome
15 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
8225 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
29 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8240 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-42825 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-38537 usd
CY2023 arrt Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.01
CY2022 arrt Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.01
CY2023 arrt Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
4400048 shares
CY2022 arrt Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
4400048 shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-182216 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1470 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-38537 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-219283 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1855 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-42825 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-260253 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-42825 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-38537 usd
CY2023 us-gaap Adjustment For Amortization
AdjustmentForAmortization
3000 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2875 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1855 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1470 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
8225 usd
CY2023 us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
-29 usd
CY2022 us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
15 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8224 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-16449 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6163 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
13336 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35938 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29065 usd
CY2023 arrt Asset Purchase Of Within Without Granola
AssetPurchaseOfWithinWithoutGranola
0 usd
CY2022 arrt Asset Purchase Of Within Without Granola
AssetPurchaseOfWithinWithoutGranola
-10000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
24450 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
51719 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24450 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
51719 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-11488 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
12654 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13555 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
901 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2067 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13555 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2022Q2 us-gaap Inventory Write Down
InventoryWriteDown
16449 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
8225 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
2541 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
0 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
8224 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
1855 usd
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.28 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.28 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.28 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.21 pure
CY2023Q2 arrt Retained Earning Accumulated Deficit
RetainedEarningAccumulatedDeficit
-19258251 usd
CY2023 us-gaap Adjustment For Amortization
AdjustmentForAmortization
3000 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
2875 usd
CY2023 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
29 usd
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-15 usd
CY2016Q3 arrt Due From Related Party
DueFromRelatedParty
168666 usd
CY2023Q2 arrt Due From Related Party
DueFromRelatedParty
168666 usd
CY2022Q2 arrt Due From Related Party
DueFromRelatedParty
154216 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4400048 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5392310 usd
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4035239 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5392310 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4035239 usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd

Files In Submission

Name View Source Status
0001477932-23-007594-index-headers.html Edgar Link pending
0001477932-23-007594-index.html Edgar Link pending
0001477932-23-007594.txt Edgar Link pending
0001477932-23-007594-xbrl.zip Edgar Link pending
arrt-20230630.xsd Edgar Link pending
arrt_10k.htm Edgar Link pending
arrt_ex311.htm Edgar Link pending
arrt_ex312.htm Edgar Link pending
arrt_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
arrt-20230630_lab.xml Edgar Link unprocessable
arrt-20230630_pre.xml Edgar Link unprocessable
arrt-20230630_cal.xml Edgar Link unprocessable
arrt-20230630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
arrt_10k_htm.xml Edgar Link completed